NCT00482287View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics of MTR105 in Hypotensive Cardiac Surgery Patients

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
HypotensionCardiopulmonary Bypass
Interventions
DRUG

MTR105

Intravenous administration, dose escalating (4 arms), single dose

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

Sponsors
All Listed Sponsors
lead

Meditor Pharmaceuticals Ltd.

INDUSTRY

NCT00482287 - Pharmacokinetics and Pharmacodynamics of MTR105 in Hypotensive Cardiac Surgery Patients | Biotech Hunter | Biotech Hunter